The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's disease
Open Access
- 19 November 2012
- Vol. 2 (6), e001893
- https://doi.org/10.1136/bmjopen-2012-001893
Abstract
Epidemiological studies indicate that significant decreases in the incidence of Alzheimer's disease (AD) may be obtained by targeting multiple middle-age risk factors. However, as dementia is unlikely to be diagnosed for decades, short-term outcome measures are required. AD biomarker changes precede clinical symptoms by many years, but their sensitivity to mid-life change remains unknown. PREVENT is a prospective cohort study examining biomarker status at mid-life in at least 150 individuals genetically at high, medium or low risk of late-onset AD. Participants are children of individuals with or without a diagnosed AD allocated to high, medium and low-risk groups according to parental clinical status and ApoE genotype. The biomarkers examined over 2 years are plasma and CSF Aβ42 amyloid, Tau and pTau, proinflammatory cytokines, acute-phase proteins, medial temporal-lobe atrophy, white matter lesion volume, cognitive performance related to transentorhinal and hippocampal functioning and hypothalamic−pituitary−adrenal and sympathetic axes regulation. Detected pathologies are communicated to the participant's general practitioner with their permission. Risk status by genotype would not be revealed. The results of the study would be published in peer-reviewed journals and validated biomarkers used to construct a randomised controlled intervention study.Keywords
This publication has 50 references indexed in Scilit:
- Amyloid Plaques Dissociate Pentameric to Monomeric C‐Reactive Protein: A Novel Pathomechanism Driving Cortical Inflammation in Alzheimer's Disease?Brain Pathology, 2011
- Cross-sectional and 35-year longitudinal assessment of salivary cortisol and cognitive functioning: The Vietnam Era Twin Study of AgingPsychoneuroendocrinology, 2011
- The projected effect of risk factor reduction on Alzheimer's disease prevalenceThe Lancet Neurology, 2011
- Developing a Dementia Research Registry: a descriptive case study from North Thames DeNDRoN and the EVIDEM programmeBMC Medical Research Methodology, 2011
- Salivary cortisol and prefrontal cortical thickness in middle-aged men: A twin studyNeuroImage, 2010
- Alzheimer's Disease Neuroimaging Initiative (ADNI)Neurology, 2010
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairmentBrain, 2008
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- Cognitive dysfunction 1–2 years after non‐cardiac surgery in the elderlyActa Anaesthesiologica Scandinavica, 2000